Hinge Health (NYSE:HNGE) Price Target Raised to $107.00

Hinge Health (NYSE:HNGE) had its price objective boosted by research analysts at Citizens Jmp from $96.00 to $107.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “market outperform” rating on the stock. Citizens Jmp’s price target suggests a potential upside of 21.23% from the stock’s previous close.

A number of other research firms also recently issued reports on HNGE. Royal Bank Of Canada reiterated an “outperform” rating and set a $110.00 price target on shares of Hinge Health in a research note on Wednesday. Citigroup reissued an “outperform” rating on shares of Hinge Health in a research note on Monday, July 27th. Wall Street Zen downgraded Hinge Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 6th. Wells Fargo & Company increased their price target on Hinge Health from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Finally, Piper Sandler restated an “overweight” rating on shares of Hinge Health in a research note on Wednesday, June 10th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $96.33.

Hinge Health Stock Performance

Shares of Hinge Health stock traded up $8.84 during trading hours on Wednesday, reaching $88.26. The company’s stock had a trading volume of 1,849,223 shares, compared to its average volume of 1,506,248. Hinge Health has a one year low of $30.08 and a one year high of $91.50. The company has a market capitalization of $6.83 billion, a P/E ratio of -7.15 and a beta of 1.30. The stock’s fifty day simple moving average is $74.52 and its two-hundred day simple moving average is $54.18.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.31. The firm had revenue of $212.82 million during the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The firm’s quarterly revenue was up 53.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 earnings per share. As a group, research analysts forecast that Hinge Health will post 1.37 earnings per share for the current year.

Insider Buying and Selling at Hinge Health

In related news, Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $60.22, for a total value of $5,018,373.48. Following the sale, the chairman directly owned 83,334 shares in the company, valued at approximately $5,018,373.48. The trade was a 50.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Insight Holdings Group, Llc sold 1,466,667 shares of the stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $82.83, for a total transaction of $121,484,027.61. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,766,556 shares of company stock valued at $290,713,052 in the last quarter. 18.92% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Hinge Health

A number of large investors have recently made changes to their positions in HNGE. Vista Investment Partners LLC bought a new stake in shares of Hinge Health during the 2nd quarter valued at $3,468,000. Assenagon Asset Management S.A. purchased a new stake in Hinge Health during the 2nd quarter worth about $6,867,000. California State Teachers Retirement System boosted its stake in Hinge Health by 35.2% in the 1st quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after purchasing an additional 4,986 shares during the period. Estuary Capital Management LP purchased a new position in Hinge Health during the 1st quarter valued at about $15,201,000. Finally, Lazard Asset Management LLC grew its holdings in Hinge Health by 0.6% during the 1st quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock valued at $2,456,000 after buying an additional 386 shares in the last quarter.

Trending Headlines about Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Strong second-quarter performance: Hinge Health reported $212.8 million in revenue, up 53% year over year, and earnings of $0.59 per share. That exceeded the $0.28 consensus estimate cited by MarketBeat, although Zacks characterized the result as in line with its own consensus. The company also said free cash flow more than tripled from the prior year. Hinge Health reports record second-quarter 2026 financial results
• Positive Sentiment: Above-consensus third-quarter outlook: Management forecast third-quarter revenue of $223 million to $225 million, well above the roughly $211 million analyst consensus. The guidance reinforces expectations for continued strong growth. Hinge Health earnings conference call
• Positive Sentiment: Analyst target raised: Needham increased its price target from $76 to $97 and assigned a “Buy” rating, implying substantial upside from recent trading levels. Benzinga analyst update
• Positive Sentiment: Expansion into gastrointestinal care: Hinge Health agreed to acquire Cylinder Health for $105 million in cash. The deal is intended to add a virtual-first GI Care Program to its existing musculoskeletal and migraine offerings, expanding its addressable market. Hinge Health to acquire Cylinder Health
• Neutral Sentiment: CEO Daniel Perez’s earnings interview and the Q2 earnings call provide additional detail on the company’s operating performance, strategy and outlook. Daniel Perez Hinge Health CEO interview
• Negative Sentiment: Profitability remains a risk: Despite the quarterly EPS beat, Hinge Health continues to report a negative net margin and negative return on equity. The $105 million all-cash acquisition also creates execution and integration risks.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.